News

Padrik P, Tõnisson N, Hovda T, Sahlberg KK, Hovig E, Costa L, Nogueira da Costa G, Feldman I, Sampaio F, Pajusalu S, Ojamaa K, Kallak K, Tihamäe AT, Roht L, Kahre T, Lepland A, Sõber S, Kruuv-Käo K, Tamm M, Varghese J, Evans DG, AnteNOR and BRIGHT Research Consortia (2025)
Guidance for the Clinical Use of the Breast Cancer Polygenic Risk Scores
Cancers (Basel), 17 (7)
DOI 10.3390/cancers17071056, PubMed 40227593

Larrinaga G, Solano-Iturri JD, Arrieta-Aguirre I, Valdivia A, Lecumberri D, Iturregui AM, Lawrie CH, Armesto M, Dorado JF, Nunes-Xavier CE, Pulido R, López JI, Angulo JC (2025)
Prognostic and Therapeutic Implications of Alamandine Receptor MrgD Expression in Clear Cell Renal Cell Carcinoma with Development of Metastatic Disease
Biomolecules, 15 (3)
DOI 10.3390/biom15030387, PubMed 40149923

Pallarès-Sastre M, Amayra I, Pulido R, Nunes-Xavier CE, Bañuelos S, Cavaliere F, García M (2025)
Cognitive and Adaptive Functioning of CTNNB1 Syndrome Patients: A Comparison With Autism Spectrum Disorder and Cerebral Palsy
J Intellect Disabil Res (in press)
DOI 10.1111/jir.13235, PubMed 40145647